SRLV Exosomes
SRLV Human adipose-derived exosomes used to boost skin regeneration, reduce inflammation and accelerate healing also to enhance outcomes in aesthetic treatments.
Exosomes are tiny, naturally occurring vesicles that act as messengers between cells. They play a crucial role in tissue repair, cell communication, and skin health, making them a powerful tool in aesthetic and regenerative medicine.
SCIENCE & TECHNOLOGY
Powered By Innovative ExoSCRT ™ isolation and purification technology exceeding the industry standard.
Exosome, an 30~200 nm endoplasmic reticulum that is secreted for cell-to-cell communication, plays an important role in influencing the microenvironment around cells, ExoSCRT™ is an innovative technology to separate and refine 0.1% pure exosomes from stem cells and helps the virtualization of natural skin energy by affecting skin cells effectively.
InMode Australia x ExoCoBio
InMode Australia and ExoCoBio, a leading cosmeceutical and Biopharmaceutical company based in Korea have joined forces to introduce cutting edge Exosome Solutions to the Australian and New Zealand markets. ExoCoBio, is a distinguished leader in the field of exosome research, development and manufacturing. With a dedication to advancing regenerative medicine and life sciences, it has garnered international recognition for its cutting-edge exosome products.
This collaboration marks a significant milestone in the healthcare and aesthetics industry.
Exosomes are naturally occurring nanoparticles that enable communication between cells. They carry growth factors, proteins, peptides and genetic material that support skin repair and regeneration. In aesthetic treatments, exosomes are used to enhance healing, improve skin quality and support collagen production following procedures.
Exosomes help signal skin cells such as fibroblasts and keratinocytes to support repair, regeneration and healthy cellular activity. When applied after aesthetic procedures, they assist with recovery and optimise treatment outcomes.
ASCE+ is a professional topical exosome system developed by ExoCoBio using patented ExoSCRT™ technology. It is designed for post-procedure application to support skin and scalp regeneration following aesthetic treatments.
ExoSCRT™ is ExoCoBio’s proprietary isolation and lyophilisation process that allows exosomes to be purified, stabilised and preserved without compromising protein integrity.
Each box contains one vial of lyophilised exosomes and one vial of official ExoCoBio diluent. The diluent contains hyaluronic acid, amino acids, minerals and growth factors that optimise hydration and delivery when the product is reconstituted.
ASCE+ exosomes are derived from ethically sourced human adipose-derived stem cells. No live cells are present in the final product.
Yes. Donors are screened according to MFDS and international cell therapy guidelines to minimise disease risk and ensure safety.
Yes. ExoCoBio manufactures exosomes in dedicated GMP facilities and maintains multiple master cell banks to ensure batch-to-batch consistency.
Yes. ASCE+ undergoes sterilisation and strict quality control processes. The product is intended for topical cosmetic use only.
When used topically as directed, allergic reactions are extremely rare. Most post-treatment redness or swelling relates to the procedure itself rather than the exosomes.
ASCE+ is applied topically immediately after procedures that enhance skin permeability, such as RF microneedling, microneedling, laser treatments, chemical peels and PRP.
ASCE+ is designed to be used after procedures that create micro-channels in the skin. Application on intact skin alone may significantly reduce absorption and treatment results.
The full vial of official diluent is added to the lyophilised exosome vial and mixed gently until fully dissolved. The entire contents are then applied to the treated area.
ASCE+ should be used immediately after reconstitution and within three hours. Any unused product must be discarded and must not be stored or reused.
Unopened vials should be stored at room temperature, away from direct heat and sunlight.
No. ASCE+ is approved for topical cosmetic use only. Injecting is considered Off Label, and must not be injected or used intravenously.
ASCE+ is supplied to trained medical, dermal and aesthetic professionals for in-clinic use in conjunction with approved procedures and protocols.
ASCE+ is supplied in accordance with Australian cosmetic regulations for professional topical use. It is not a registered therapeutic good and is not classified as a medicine or injectable product.
No. Once mixed, ASCE+ must be used immediately and any remaining product must be discarded.
Many patients notice improved hydration, glow and reduced redness within days. Ongoing skin quality and collagen improvements continue over several weeks.
Protocols vary, but many clinics recommend a course of three sessions spaced four to six weeks apart, followed by maintenance as advised by the practitioner.
Yes. ASCE+ is commonly used post-microneedling or device-based scalp treatments to support scalp health and hair regeneration protocols.